Skip to content

Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes

Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00739180
Enrollment
45
Registered
2008-08-21
Start date
2007-11-30
Completion date
2011-10-31
Last updated
2012-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Obesity

Keywords

Childhood obesity, Abdominal obesity, Visceral fat, Insulin resistance, Liver fat, Skeletal muscle lipid, Fitness

Brief summary

In this randomized controlled trial, we will examine the effect of a 3-month exercise training (aerobic exercise versus resistance exercise) without calorie restriction on total and regional adiposity, and risk of type 2 diabetes in overweight children and adolescents.

Interventions

OTHERControl

Standard care control (no exercise)

OTHERResistance Exercise

Supervised resistance exercise using stack weight equipments.

OTHERAerobic exercise

Supervised aerobic exercise using treadmills, bikes, and ellipticals

Sponsors

American Diabetes Association
CollaboratorOTHER
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
12 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy overweight (BMI \>-95th) youth between 12 and 18 years of age * Waist circumference \>-75th percentile * Sedentary (no structured exercise \>2 times/week for past 6 months) * Non-smokers, non-diabetic, no medical conditions * Weight stable for past 3 months

Exclusion criteria

* Smokers, * diabetic, * psychiatric disorders, * syndromatic obesity

Design outcomes

Primary

MeasureTime frame
Abdominal obesity, visceral fat3 month

Secondary

MeasureTime frame
Insulin sensitivity and secretion, glucose tolerance3 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026